Clinical Trial Update: A Study of SHR-1210 in Combination With Apatinib or Chemotherapy in Subjects With Advanced PLC or BTC [Phase 2]

View source ↗

Summary

Phase 2 trial update for SHR-1210 in combination with Apatinib or chemotherapy in advanced hepatocellular carcinoma or biliary tract cancer; results have been p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Hepatocellular Carcinoma

Drugs mentioned

• Apatinib (apatinib)
• SHR-1210 (camrelizumab)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Advanced Primary Liver Cancer, Advanced Biliary Tract Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2026-01-29